About MolecuLight
MolecuLight is a Canadian medical imaging company that develops and manufactures portable, handheld fluorescence imaging devices for point-of-care wound assessment. Their primary products, the MolecuLight i:X and MolecuLightDX, utilize safe violet light to visualize and localize bacteria with loads greater than 10^4 CFU/g in wounds in real-time. This technology allows clinicians to identify clinically significant bacterial burden that may not be evident through visual inspection alone, aiding in more informed decision-making regarding wound cleaning, debridement, and treatment selection.
For physicians, the MolecuLight devices offer a non-invasive, contrast-free method to assess wounds, providing immediate, objective information about bacterial presence and distribution. This can lead to more targeted therapies, potentially shortening healing times, reducing the unnecessary use of antibiotics, and avoiding complications related to infection. The devices also provide digital wound area measurement and documentation capabilities, which can be integrated with Electronic Health Records (EHRs) for comprehensive patient management and tracking of wound healing over time. The MolecuLight procedure is reimbursed with dedicated CPT codes for physician work and facility payments through APC assignment for hospital outpatient and ASC settings.
Recent advancements include the integration of thermal imaging for non-contact skin temperature visualization and plans for 3D wound visualization. The company’s technology is designed to improve patient outcomes by empowering healthcare providers with tools to quickly and accurately identify and quantify bacteria that impair wound healing across various care settings, including hospital outpatient, independent wound care clinics, podiatry practices, and long-term care centers.
Focus Areas
Business Intelligence
| Technology | Proprietary fluorescence imaging platform technology, handheld imaging devices (MolecuLight i:X, MolecuLightDX), violet light illumination, dual bandpass optical filter, thermal imaging module, EHR integrated, cloud-based multimedia archive, secure platform (HIPAA, SOC II Type 2) |
What Physicians Need to Know
For physicians, MolecuLight offers a powerful tool to enhance clinical decision-making and improve patient outcomes in wound care. The real-time visualization of bacteria allows for targeted interventions, leading to more effective debridement and optimized treatment plans. This can result in faster healing, reduced antibiotic use and costs, shorter hospital stays, and a lower risk of complications. The digital wound measurement capabilities provide objective data for tracking wound progression and assessing treatment efficacy. Furthermore, the technology serves as a valuable teaching tool for younger physicians in understanding infection control and intraoperative wound assessment. MolecuLight also supports equitable care by improving bacterial detection across all skin tones.
MolecuLight's flexible architecture supports integration with most EMR platforms, including Epic (available on the Epic App Market) and Net Health's Tissue Analytics and WoundExpert. This allows for seamless transfer of standard, fluorescence, and measurement images directly to the patient's record, providing a more complete set of documentation and enabling clinicians to view and compare wound progression over time.
What the Web Says
MolecuLight is a company that develops and manufactures fluorescence imaging devices, such as the MolecuLight i:X and DX, for real-time detection of elevated bacterial burden in wounds. These devices aim to improve wound care by guiding treatment decisions, enhancing assessment, and monitoring efficacy. While product reviews from healthcare professionals are generally positive, employer reviews on platforms like Indeed.com indicate a negative sentiment regarding the company's work environment and management practices.
Overall: MixedStrengths
- Real-time detection of elevated bacterial burden in wounds
- Guides treatment decisions, including cleansing, debridement, and sampling
- Enhances assessment by objectively determining the presence and location of bacteria
- Provides accurate digital wound measurement and documentation
- Can lead to improved patient outcomes and cost savings by preventing unnecessary procedures
- Portable, handheld, and easy to integrate into clinical workflow
Limitations
- Toxic atmosphere and cliques reported by employees
- Abusive and unapproachable management
- Unreasonable workload and understaffing
- Lack of work-life balance
- Non-existent promotion process
- Management not connected to employees; lots of politics
Based on reviews from: Indeed.com, YouTube, WoundSource, Lower Extremity Review Magazine, MolecuLight.com, Reddit
Last updated: 2026-08-25
Videos
News, demos, and interviews about MolecuLight.
Videos load interactively. If none appear, search YouTube for MolecuLight →
Press & Coverage
Frequently Asked Questions
Related Companies
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]
The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]
SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]
PHQ Screeners is a free, open-access resource maintained by Pfizer, providing a comprehensive suite of Patient Health Questionnaire (PHQ) and Generalized Anxiety Disorder (GAD-7) screening instruments. These tools were developed by Drs. Robert L. Spitzer, Janet B.W. Williams, and Kurt Kroenke with an educational grant from Pfizer, and are widely utilized in primary care and […]